<DOC>
	<DOCNO>NCT03014544</DOCNO>
	<brief_summary>The purpose study compare psychometric property ( performance validity ) 8 individual cognitive test computer-administered cognitive test battery intend assessment cognitive function participant major depressive disorder ( MDD ) either partial full remission 8 correspond standard , non-reference , examinerâ€‘administered cognitive test .</brief_summary>
	<brief_title>Study Evaluate Performance Validity Test-Retest Reliability Computer-Administered Cognitive Test Battery Participants With Major Depressive Disorder ( MDD )</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<criteria>) Substudy A Main Study : Primary diagnosis Major depressive disorder ( MDD ) partial full remission , make confirm investigator accord Diagnostic Statistical Manual Mental Disorders5 ( DSM5 ) criterion Demonstrated adequate clinical response within past 12 month , currently maintain response , stable oral antidepressant treatment regimen 2 Selective serotonin reuptake inhibitor ( SSRI ) , Serotoninnorepinephrine reuptake inhibitor ( SNRI ) , bupropion antidepressant , without dose change recent 6 week . The dose duration treatment document investigator use Massachusetts General Hospital Antidepressant Treatment Response Questionnaire ( MGHATRQ ) verify available medical pharmacy record Required MontgomeryAsberg Depression Rating Scale ( MADRS ) total score less equal ( &lt; = ) 17 screen baseline ( Test Day 1 ) visit well less equal ( &lt; = ) 19 subsequent test day ( main study ) . Participants also require Clinical Global Impression Severity ( CGIS ) total score &lt; =3 test day ( main study ) Must normal visual hearing acuity determine physical examination b ) Substudy B ( Healthy Participants ) : Must healthy basis physical examination , vital sign examination , medical history perform screen . This determination must record participant 's source document initial investigator Body mass index ( weight [ kilogram ( kg ) ] /height^2 [ meter ( ) ] ^2 ) 18 30 kg/m2 ( inclusive ) Blood pressure ( participant sit 5 minute ) 90 140 millimeter mercury ( mmHg ) inclusive , systolic , high 90 mmHg diastolic Must sign Informed consent form ( ICF ) indicate understands purpose , procedure require , study willing participate study ) Substudy A Main Study : Has follow acute chronic psychiatric condition , accord Diagnostic Statistical Manual Mental Disorders5 ( DSM5 ) criterion : Major depressive disorder ( MDD ) psychotic feature ( lifetime ) , bipolar disorder ( include lifetime diagnosis ) , obsessivecompulsive disorder , posttraumatic stress disorder , borderline personality disorder , anorexia nervosa , schizophrenia , schizoaffective disorder , minor major neurocognitive disorder ( include dementia ) History acute chronic neurological condition ( example ( eg ) , stroke , epilepsy , Parkinson 's disease ) b ) Substudy B ( Healthy Participants ) : History drug alcohol abuse , severity least moderate severe , accord DSM5 criterion , within 6 month screen positive test result ( ) alcohol drug abuse ( include barbiturate , opiate , cocaine , cannabinoids , amphetamine benzodiazepine ) screen Participant clinically significant liver renal insufficiency ; cardiac , vascular , pulmonary , gastrointestinal , endocrine , neurologic , hematologic , rheumatologic , psychiatric , metabolic disturbance . A significant primary sleep disorder exclusionary , include primary insomnia hypersomnia , narcolepsy , breathingrelated sleep disorder , circadianrhythm sleep disorder , dyssomnias otherwise specify Has condition , opinion investigator , participation would best interest participant ( example , compromise wellbeing ) could prevent , limit , confound protocolspecified assessment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>59 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>